Life Sciences and Diagnostics Business Help Drive up Danaher Q2 Sales 15 Percent

During a conference call, Danaher's CEO said that although issues surrounding broad quality systems at Beckman Coulter, as well issues with FDA are improving, there "is plenty of work ahead of us."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.